Related Experiment Video
Updated: Sep 4, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning
Jennifer L Alejo1, Jonathan Mitchell1, Teresa P-Y Chiang1
1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Solid organ transplant recipients often have a poor antibody response to COVID-19 vaccines. Key risk factors include mycophenolate mofetil, recent transplant, and older age, guiding personalized vaccination strategies.
Area of Science:
- Immunology
- Vaccinology
- Transplant Medicine
Background:
- Solid organ transplant recipients (SOTRs) exhibit diminished antibody responses to SARS-CoV-2 mRNA vaccines.
- Identifying factors associated with poor vaccine response is crucial for optimizing SOTR immunity.
Purpose of the Study:
- To develop and validate a machine learning model predicting antibody response to SARS-CoV-2 mRNA vaccines in SOTRs.
- To identify and rank clinical factors influencing vaccine immunogenicity in this vulnerable population.
Main Methods:
- A nationwide cohort of 1031 SOTRs was used to build a machine learning model.
- 19 clinical factors were analyzed for their association with antibody response after two vaccine doses.
- External validation was performed on a separate cohort of 512 SOTRs.
Main Results:
- Mycophenolate mofetil use, shorter time since transplant, and older age were the strongest predictors of a negative antibody response.
- These factors accounted for 76% of the model's predictive performance.
- The model achieved an AUC of 0.79 in the primary cohort and 0.67 in the validation cohort.
Conclusions:
- The machine learning model aids in identifying SOTRs requiring closer monitoring and potential additional vaccine doses.
- An accessible online calculator can assist clinicians in risk stratification and tailoring vaccination strategies for SOTRs.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017